July 9, 2014 | Letter
Excerpt: Pursuant to Rules X and XI of the U.S. House of Representatives, the Committee is examining an incident last month at the Centers for Disease Control and Prevention (CDC) involving the handling of anthrax specimens. As part of its oversight and in preparation for an upcoming hearing, the Committee is gathering pertinent background information and documents related to biosafety issues and the CDC laboratories. 
July 9, 2014 | Letter
21 C, The Coalition For 21st Century Patent Reform  American Bankers Association 
June 23, 2014 | Letter
AEC Science & Technology, LLC Alliance for Water Efficiency (AWE)
June 19, 2014 | Letter
To read the letter from HHS, click here. To read an attachment to the letter, click here. 
June 16, 2014 | Letter
American Chemistry Council  Chamber of Commerce of the United States of America 
June 10, 2014 | Letter
Exerpt: As you know, Section 1342 of the Patient Protection and Affordable Care Act (PPACA, P.L. 111-148) directs the Secretary of Health and Human Services (HHS) to operate a risk corridor program to limit the profits and losses of qualified health plans in the individual and small group markets. However, the provision does not specify a source of funding for the program.